Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för latanoprost free acid. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

9 träffar

Bibliografisk träff 2011-12-02

Comparison of human ocular distribution of bimatoprost and latanoprost.

Ichhpujani P, Katz LJ, Hollo G, Shields CL, Shields JA, Marr B, Eagle R, Alvim H, Wizov SS, Acheampong A, Chen J, Wheeler LA.

J Ocul Pharmacol Ther · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1089/jop.2011.0097

Bibliografisk träff 2011-11-01

Development and validation of a liquid chromatography/electrospray ionization tandem mass spectrometry method for the quantification of latanoprost free acid in rabbit aqueous humor and ciliary body.

Zammataro A, Civiale C, Saletti R, Foti S.

J Mass Spectrom · journal article · DOI 10.1002/jms.2004

Bibliografisk träff 2011-07-26

Neuroprotective effects of prostaglandin analogues on retinal ganglion cell death independent of intraocular pressure reduction.

Yamagishi R, Aihara M, Araie M.

Exp Eye Res · journal article · DOI 10.1016/j.exer.2011.06.022

Bibliografisk träff 2011-07-23

Latanoprost systemic exposure in pediatric and adult patients with glaucoma: a phase 1, open-label study.

Raber S, Courtney R, Maeda-Chubachi T, Simons BD, Freedman SF, Wirostko B, A6111139 Study Group.

Ophthalmology · research support, non-u.s. gov't; multicenter study; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1016/j.ophtha.2011.03.039

Bibliografisk träff 2011-03-09

Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.

Krauss AH, Impagnatiello F, Toris CB, Gale DC, Prasanna G, Borghi V, Chiroli V, Chong WK, Carreiro ST, Ongini E.

Exp Eye Res · journal article · DOI 10.1016/j.exer.2011.03.001

Bibliografisk träff 2009-12-17

The prostaglandin transporter OATP2A1 is expressed in human ocular tissues and transports the antiglaucoma prostanoid latanoprost.

Kraft ME, Glaeser H, Mandery K, König J, Auge D, Fromm MF, Schlötzer-Schrehardt U, Welge-Lüssen U, Kruse FE, Zolk O.

Invest Ophthalmol Vis Sci · research support, non-u.s. gov't; journal article · DOI 10.1167/iovs.09-4290

Bibliografisk träff 2009-03-14

Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein.

Errasti AE, del-Rey G, Cesio CE, Souza G, Nowak W, Pelorosso FG, Daray FM, Rothlin RP.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2009.03.022

Bibliografisk träff 2008-12-03

Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo.

Kanamori A, Naka M, Fukuda M, Nakamura M, Negi A.

Exp Eye Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.exer.2008.11.012

Bibliografisk träff 2008-05-01

The mechanisms by which latanoprost free acid inhibits human carbonic anhydrase I and II.

Sugimoto A, Ikeda H, Tsukamoto H, Kihira K, Takeda C, Hirose J, Hata T, Baba E, Ono Y.

Biol Pharm Bull · research support, non-u.s. gov't; journal article · DOI 10.1248/bpb.31.796